Ankit Mangla, MD
-
Specialty: Hematology and Oncology
View Expertise - Languages Spoken: English, Hindi
Office Locations
UH Seidman Minoff Health Center (7 mi.)
3909 Orange Pl
Ste 4400
Beachwood, OH 44122
216-896-1750
UH Seidman Avon Health Center (22 mi.)
2075 Healthway Dr
2nd Floor
Avon, OH 44011
440-517-9000
Biography: Ankit Mangla, MD
Expertise
Titles
- Co-Director, Sarcoma and Cutaneous Oncology Team, UH Seidman Cancer Center
- Assistant Professor, CWRU School of Medicine
Certifications & Memberships
- Medical Oncology - American Board of Internal Medicine
- Hematology - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Education
Fellowship | Hematology/Oncology
Hematology/Oncology - John H Stroger, Jr Hospital Of Cook County (2015 - 2018)
Residency | Internal Medicine
Internal Medicine - John H Stroger, Jr Hospital Of Cook County (2012 - 2015)
Medical Education
Armed Forces Medical College, Maharashtra University Of Health Sciences (2007)
About
Ankit Mangla, MD, is a medical oncologist at University Hospitals Seidman Cancer Center with expertise in treating patients with melanoma and rare tumors such as Merkel cell cancer and soft tissue sarcoma. His specific areas of interest are the use of neoadjuvant immunotherapy in patients diagnosed with melanoma and drug development. He also serves as the Co-Director (Medical Oncology) of the sarcoma and melanoma disease teams.
Dr. Mangla earned his medical degree from Armed Forces Medical College in India and served in the Army Medical Corps of the Indian Army for five years. He completed a residency in internal medicine followed by a fellowship in hematology and oncology at the John H. Stroger Jr. Hospital of Cook County in Chicago, Illinois. Dr. Mangla joined University Hospitals/Case Western Reserve University in 2018. His philosophy for cancer treatment is developing a patient-centric treatment plan focusing on minimizing toxicity while achieving maximum efficacy.
As a clinical investigator at UH Seidman Cancer Center, Dr. Mangla serves as a principal investigator for several phase I, II and III clinical trials, focused on improving the treatment of melanoma and soft tissue sarcomas. Dr. Mangla has authored several research papers in high-impact journals such as the New England Journal of Medicine, Journal of Clinical Oncology and JAMA Oncology. He was one of the investigators on the SWOG-1801 study studying the effects of neoadjuvant pembrolizumab in patients with melanoma. Conducted through the Southwest Oncology Group, this trial defined a new standard of care for patients with clinical stage 3 melanoma. Results of the trial were published in the New England Journal of Medicine.
Dr. Mangla participates in several oncology consortiums and actively contributes to drug development discussions. He is also an associate editor for Current Problems in Cancer: Case Reports and an editorial board member for Translational Oncology, Cancer Treatment and Research Communications, and World Journal of Clinical Cases. In addition, he has served as a reviewer for the Journal of Oncology Practice, Annals of Translational Oncology and Thoracic Cancers, among other peer-reviewed journals.
Dr. Mangla has been an invited lecturer, expert panelist and poster presenter at numerous annual meetings and conferences, including events hosted by the Multiple Myeloma Rounds, Midwest Melanoma and High-Risk Cancer Symposium, UH Seidman Cancer Center, American College of Physicians, American Society of Clinical Oncology, Society of General Internal Medicine, European Society of Medical Oncology, and European Congress of Internal Medicine. Dr. Mangla is a member of professional societies including the American College of Physicians, American Society of Clinical Oncology, Society for Immunotherapy of Cancer, Connective Tissue Oncology Society, and International Cardiology Oncology Society.
Featured Videos
Watch to find out more about this University Hospitals provider.
Patient Experience Reviews
He explained everything so that I understood and seemed very caring about what I was going through
Outstanding care from Dr Mangla
Dr. Mangla is a great doctor.
Great Dr, I am happy to have him.
I like Dr. Mangla a lot, he's always willing to answer all of my questions. He's very polite and caring.
Very are quite pleased with Dr Mangla
Good
Dr Mangla is very caring, easy to understand and always listens to my replies.
Dr. Mangla and his nurse *** are phenomenal. Dr. Mangla is very trustworthy and I feel he has my best interest at heart.
Very informative and understanding
The care I was given by the team of people could not have been better. Thank you Team. Especially Dr Mangla !
Everyone is very friendly, helpful, kind and considerate.
Dr. Mangla takes the time needed to explain and listen to my concerns.
Dr Mangla and his team are professional caring and friendly. I am grateful for the privilege of getting my care at UH Seidman. I know I am respected and receiving the best care available
From the receptionists to nurses are great! My physician is the best.
Great Dr. and nurses!!
I am so pleased with the UH organization. I feel safe and that I am getting the best care possible
I'm being treated for sarcoma, which is not a common cancer. Dr. Mangla is very knowledgeable. He was to the point but still very kind. I appreciate that.
Dr. Mangla is very (down to earth) care provider, felt very comfortable with him , he is a asset to this office
Good
The Doctor was prepared and reviewed each scan with me pointing out items that aided me in understanding my situation and care being provided greatly.
Great
Dr. Mangla is very knowledgeable and takes the time to explain, answers your questions.
Dr. Mangla thoroughly explained my condition, the treatment I needed and how it works in a kind and respectful manner.
We're quite pleased with the entire visit.
Very good
I have had the best care since coming to University hospital and Dr. Mangla is the best!
Dr Mangla and nurse *** are wonderful care providers. Their concern and attention to me goes beyond expectations.
It's hard being in the position I am in, but Dr. Mangla is doing everything possible to help me have a longer life.
Dr. Mangla is so personal. He answers every question and makes sure I understand any decision that need to be addressed
Dr. Mangla and Nurse *** are awesome!
Dr Mangla is so very good at explaining and making sure I fully understand the treatment I will be receiving.
Great, great Doctor!
Dr Mangla did a super job explaining my upcoming Chemo in every detail. He put me at peace with my decision. I am so thankful for his expertise.
Dr. Mangla was very personable as well as professional. I was seeing him on consult because after 3 scans & a biopsy, it was still unclear whether or not I had a reoccurrence of ***. My oncologist referred me. He reviewed all of the tests & reassured me that I had no signs of cancer & also informed me that my chances of reoccurrence are extremely minimal. He said there was no need to physically examine me as he thoroughly reviewed all of the Imaging & biopsy results. Obviously, I was very relieved by his assessment. He seemed very knowledgeable, as my oncologist confirmed, & I was very satisfied with the visit.
Very professional and kind
Good
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Ankit Mangla did not disclose any Outside Relationships with Industry.